Logo image of PTE

POLARITYTE INC (PTE) Stock Price, Quote, News and Overview

NASDAQ:PTE - Nasdaq - US7310942070 - Common Stock - Currency: USD

0.241  0 (-0.82%)

After market: 0.2249 -0.02 (-6.68%)

PTE Quote, Performance and Key Statistics

POLARITYTE INC

NASDAQ:PTE (6/15/2023, 8:20:22 PM)

After market: 0.2249 -0.02 (-6.68%)

0.241

0 (-0.82%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.9
52 Week Low0.2
Market Cap1.78M
Shares7.38M
Float7.13M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-09 2023-08-09
IPO08-13 1999-08-13


PTE short term performance overview.The bars show the price performance of PTE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

PTE long term performance overview.The bars show the price performance of PTE in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PTE is 0.241 USD. In the past month the price decreased by -36.91%. In the past year, price decreased by -85.39%.

POLARITYTE INC / PTE Daily stock chart

PTE Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About PTE

Company Profile

PTE logo image PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The company is headquartered in Salt Lake City, Utah and currently employs 42 full-time employees. Its first regenerative tissue product is SkinTE. Its SkinTE is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The firm's development projects include SkinTE Point-of-Care Device, SkinTE Cryo and Other Tissue Regeneration Products. SkinTE Cryo allows it to offer multiple deployments from one original harvest through a cryopreservation process. The core technology of SkinTE is minimally polarized functional units (MPFUs). MPFUs are multi-cellular segments created from a piece of the patient’s healthy skin.

Company Info

POLARITYTE INC

1960 S. 4250 West

Salt Lake City UTAH 84116 US

CEO: David Seaburg

Employees: 42

Company Website: https://www.polarityte.com/

Phone: 13852663151.0

POLARITYTE INC / PTE FAQ

What is the stock price of POLARITYTE INC today?

The current stock price of PTE is 0.241 USD. The price decreased by -0.82% in the last trading session.


What is the ticker symbol for POLARITYTE INC stock?

The exchange symbol of POLARITYTE INC is PTE and it is listed on the Nasdaq exchange.


On which exchange is PTE stock listed?

PTE stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for POLARITYTE INC stock?

5 analysts have analysed PTE and the average price target is 0.82 USD. This implies a price increase of 238.59% is expected in the next year compared to the current price of 0.241. Check the POLARITYTE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is POLARITYTE INC worth?

POLARITYTE INC (PTE) has a market capitalization of 1.78M USD. This makes PTE a Nano Cap stock.


How many employees does POLARITYTE INC have?

POLARITYTE INC (PTE) currently has 42 employees.


What are the support and resistance levels for POLARITYTE INC (PTE) stock?

POLARITYTE INC (PTE) has a resistance level at 0.4. Check the full technical report for a detailed analysis of PTE support and resistance levels.


Is POLARITYTE INC (PTE) expected to grow?

The Revenue of POLARITYTE INC (PTE) is expected to decline by -100% in the next year. Check the estimates tab for more information on the PTE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy POLARITYTE INC (PTE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does POLARITYTE INC (PTE) stock pay dividends?

PTE does not pay a dividend.


When does POLARITYTE INC (PTE) report earnings?

POLARITYTE INC (PTE) will report earnings on 2023-08-09.


What is the Price/Earnings (PE) ratio of POLARITYTE INC (PTE)?

POLARITYTE INC (PTE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.41).


PTE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PTE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PTE. PTE has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PTE Financial Highlights

Over the last trailing twelve months PTE reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS increased by 61.44% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%74.22%
Sales Q2Q%-100%
EPS 1Y (TTM)61.44%
Revenue 1Y (TTM)-98.66%

PTE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to PTE. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 48.01% and a revenue growth -100% for PTE


Ownership
Inst Owners0%
Ins Owners114.99%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target0.82 (240.25%)
EPS Next Y48.01%
Revenue Next Year-100%